Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR spectroscopic study


Por: Draganov, M, Vives-Gilabert, Y, de Diego-Adelino, J, Vicent-Gil, M, Puigdemont, D, Portella, MJ

Publicada: 1 abr 2020
Resumen:
Background: Previous magnetic resonance spectroscopic (MRS) studies have reported brain metabolic abnormalities in Major Depressive Disorder (MDD). Nevertheless, results have been inconsistent, focusing on fully developed major depression neglecting first episode patients (FED). Longitudinal studies have also been rare and with short follow-up periods. The aim of the current study was to investigate the differences between healthy controls and first episode patients at baseline, together with changes of metabolites after 1 year follow-up in the ventromedial prefrontal cortex. Methods: H-1-MRS images were obtained from 64 healthy controls and 31 FED patients using a 3T Philips Achieva scanner and processed with TARQUIN software at baseline and after 1 year. Examined metabolites included Glx (corresponding to Glu + Gln-peak), Glu, NAAG, myo-Ins, Cr, GSH and GABA. Clinical improvement was assessed by HDRS-17 scale. Differences in the concentrations of metabolites were evaluated by MANOVA/MANCOVA and GLM repeated measures for longitudinal changes. Results: FED patients had significantly decreased glutamate levels at baseline (p < 0.05) along with significantly elevated GABA (p < 0.01) compared to healthy controls. At the follow up, myo- Ins levels were significantly increased compared to baseline (p < 0.05). Limitations: The limited sample size, together with the unexpectedly high response rate after treatment (83%) might suggest decreased representativeness of the sample. Conclusions: Results indicate glutamatergic and GABAergic changes taking place within the ventromedial prefrontal region even at the early stage of depression prior to any medication treatment.

Filiaciones:
Draganov, M:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, IIB St Pau,Dept Psychiat, Barcelona, Spain

Vives-Gilabert, Y:
 Univ Politecn Valencia, ITACA, Valencia, Spain

de Diego-Adelino, J:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, IIB St Pau,Dept Psychiat, Barcelona, Spain

Vicent-Gil, M:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, IIB St Pau,Dept Psychiat, Barcelona, Spain

Puigdemont, D:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, IIB St Pau,Dept Psychiat, Barcelona, Spain

Portella, MJ:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, IIB St Pau,Dept Psychiat, Barcelona, Spain
ISSN: 01650327





JOURNAL OF AFFECTIVE DISORDERS
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 266 Número:
Páginas: 572-577
WOS Id: 000520892700074
ID de PubMed: 32056929

MÉTRICAS